Bladder Cancer: Clinical Trials

6 trials for Bladder Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Unknown 6

Follow Bladder Cancer: new trials by email Literature Review of Bladder Cancer trials Research Report on Bladder Cancer

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma
Disitamab Vedotin for Injection,Penpulimab Injection - Bladder Cancer
Phase 4UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University482022-09-012022-08-04
Sequential Combination Therapy in Bladder Cancer
Mitomycin - Bladder Cancer
Phase 4UnknownAzienda Ospedaliera "Sant'Andrea"1402019-01-152018-12-31
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy
Diclofenac Sodium, Cystoscopy, Lubricant Gel - Bladder Cancer, Benign Prostate Hyperplasia
Phase 4UnknownTaha Uçar1442018-12-112019-02-05
Chemoradiotherapy for Recurrent T1G3 Bladder Cancer
chemoradiation - Bladder Cancer
Phase 4UnknownAssiut University202017-10-012017-09-11
Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy
Bio-tech and omega-3 plus, placebo - Bladder Cancer, Oncology
Phase 4UnknownMansoura University1002017-03-012017-05-10
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
Transurethral Resection, Tamsulosin - Bladder Cancer
Phase 4UnknownDiskapi Teaching and Research Hospital402015-02-012015-05-14

Narrower conditions

Urinary Bladder Neoplasms (6)  ·  Disease Progression (1)  ·  Hematuria (1)  ·  Infections (1)  ·  Lower Urinary Tract Symptoms (1)  ·  Neoplasms (1)  ·  Pain (1)  ·  Prostatic Hyperplasia (1)  ·  Recurrence (1)

Broader conditions

Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Male Urogenital Diseases (6)  ·  Neoplasms by Site (6)  ·  Urinary Bladder Diseases (6)  ·  Urogenital Diseases (6)  ·  Urogenital Neoplasms (6)  ·  Urologic Diseases (6)  ·  Urologic Neoplasms (6)  ·  Neoplasms (5)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Disease Attributes (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)

Interventions

BCG Vaccine (1)  ·  Chemoradiotherapy (1)  ·  Cystoscopy (1)  ·  Diclofenac (1)  ·  Docosahexaenoic Acids (1)  ·  Injections (1)  ·  Mitomycin (1)  ·  Tamsulosin (1)  ·  disitamab vedotin (1)  ·  penpulimab (1)

Sponsors

Assiut University (1)  ·  Azienda Ospedaliera "Sant'Andrea" (1)  ·  Diskapi Teaching and Research Hospital (1)  ·  Mansoura University (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  Taha Uçar (1)

Countries

Turkey (Türkiye) (2)  ·  Egypt (1)

Top investigators

Abdelwahab R. Hashem, Msc (1)  ·  Ahmed Harraz, MD (1)  ·  Ahmed Moeen (1)  ·  Ahmed Mosbah, MD (1)  ·  Andrea Tubaro (1)  ·  Atallah A. Shaaban, MD (1)  ·  Hassan Abo-Elenin, MD (1)  ·  Nihat Karakoyunlu, MD (1)  ·  Tianxin Lin (1)

Results publications

PMID 23170127, PMID 38842053

NIH funding

2017 (1)